These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 29921167)
1. Statistical analysis of Goal Attainment Scaling endpoints in randomised trials. Urach S; Gaasterland C; Posch M; Jilma B; Roes K; Rosenkranz G; Van der Lee JH; Ristl R Stat Methods Med Res; 2019 Jun; 28(6):1893-1910. PubMed ID: 29921167 [TBL] [Abstract][Full Text] [Related]
2. Goal attainment scaling as an outcome measure in rare disease trials: a conceptual proposal for validation. Gaasterland CMW; van der Weide MCJ; Roes KCB; van der Lee JH BMC Med Res Methodol; 2019 Dec; 19(1):227. PubMed ID: 31801463 [TBL] [Abstract][Full Text] [Related]
3. Discriminative versus evaluative assessment: some observations on goal attainment scaling. Ottenbacher KJ; Cusick A Am J Occup Ther; 1993 Apr; 47(4):349-54. PubMed ID: 8322875 [TBL] [Abstract][Full Text] [Related]
4. Comparable achievement of client-identified, self-rated goals in intervention and no-intervention groups: reevaluating the use of Goal Attainment Scaling as an outcome measure. Herdman KA; Vandermorris S; Davidson S; Au A; Troyer AK Neuropsychol Rehabil; 2019 Dec; 29(10):1600-1610. PubMed ID: 29430998 [TBL] [Abstract][Full Text] [Related]
5. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study. Barker D; D'Este C; Campbell MJ; McElduff P Trials; 2017 Mar; 18(1):119. PubMed ID: 28279222 [TBL] [Abstract][Full Text] [Related]
6. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849 [TBL] [Abstract][Full Text] [Related]
7. The use of goal attainment scaling during clinical medication review in older persons with polypharmacy. Verdoorn S; Blom J; Vogelzang T; Kwint HF; Gussekloo J; Bouvy ML Res Social Adm Pharm; 2019 Oct; 15(10):1259-1265. PubMed ID: 30425008 [TBL] [Abstract][Full Text] [Related]
8. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Turner-Stokes L Clin Rehabil; 2009 Apr; 23(4):362-70. PubMed ID: 19179355 [TBL] [Abstract][Full Text] [Related]
9. Goal attainment scaling: an effective outcome measure for rural and remote health services. Cox R; Amsters D Aust J Rural Health; 2002 Oct; 10(5):256-61. PubMed ID: 12230434 [TBL] [Abstract][Full Text] [Related]
10. Goal attainment scaling outcomes in general inpatient rehabilitation: association with functional independence and perceived goal importance and difficulty. Churilov I; Brock K; Churilov JM; Sutton E; Murphy D; MacIsaac RJ; Ekinci EI J Rehabil Med; 2020 Apr; 52(4):jrm00054. PubMed ID: 32286676 [TBL] [Abstract][Full Text] [Related]
11. Responsiveness of Goal Attainment Scaling in comparison to two standardized measures in outcome evaluation of children with cerebral palsy. Steenbeek D; Gorter JW; Ketelaar M; Galama K; Lindeman E Clin Rehabil; 2011 Dec; 25(12):1128-39. PubMed ID: 21795404 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the feasibility of Goal Attainment Scaling as a rehabilitation outcome measure for veterans. Lewis VJ; Dell L; Matthews LR J Rehabil Med; 2013 Apr; 45(4):403-9. PubMed ID: 23546308 [TBL] [Abstract][Full Text] [Related]
13. A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials. Gaasterland CM; Jansen-van der Weide MC; Weinreich SS; van der Lee JH BMC Med Res Methodol; 2016 Aug; 16():99. PubMed ID: 27534620 [TBL] [Abstract][Full Text] [Related]
14. Standardised approach to measuring goal-based outcomes among older disabled adults: results from a multisite pilot. Giovannetti ER; Clair CA; Jennings LA; Sandberg SF; Bowman A; Reuben DB; Scholle SH BMJ Qual Saf; 2021 Feb; 30(2):157-166. PubMed ID: 33037142 [TBL] [Abstract][Full Text] [Related]
15. The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling. Steenbeek D; Meester-Delver A; Becher JG; Lankhorst GJ Clin Rehabil; 2005 May; 19(3):274-82. PubMed ID: 15859528 [TBL] [Abstract][Full Text] [Related]
16. The responsiveness of goal attainment scaling using just one goal in controlled clinical trials: an exploratory analysis. McGarrigle L; Rockwood K J Patient Rep Outcomes; 2020 May; 4(1):35. PubMed ID: 32399731 [TBL] [Abstract][Full Text] [Related]
17. The use of goal attainment scaling in a geriatric care setting. Stolee P; Rockwood K; Fox RA; Streiner DL J Am Geriatr Soc; 1992 Jun; 40(6):574-8. PubMed ID: 1587973 [TBL] [Abstract][Full Text] [Related]
18. Sizing clinical trials when comparing bivariate time-to-event outcomes. Sugimoto T; Hamasaki T; Evans SR; Sozu T Stat Med; 2017 Apr; 36(9):1363-1382. PubMed ID: 28120524 [TBL] [Abstract][Full Text] [Related]
19. Goal attainment scaling with older people in general practice: A feasibility study. van Blijswijk SC; Gussekloo J; Heijmans FM; Wind AW; den Elzen WP; Blom JW Int J Nurs Stud Adv; 2021 Nov; 3():100015. PubMed ID: 38746730 [TBL] [Abstract][Full Text] [Related]
20. A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events. Potthoff RF; Halabi S Pharm Stat; 2015; 14(4):273-83. PubMed ID: 25894200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]